PMID- 34805421
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220428
IS  - 2325-9671 (Print)
IS  - 2325-9671 (Electronic)
IS  - 2325-9671 (Linking)
VI  - 9
IP  - 11
DP  - 2021 Nov
TI  - Failure to Achieve Threshold Scores on Patient-Reported Outcome Measures Within 1 
      Year Has a Predictive Risk of Subsequent Hip Surgery Within 5 Years of Primary 
      Hip Arthroscopy: A Case-Control Study.
PG  - 23259671211053012
LID - 10.1177/23259671211053012 [doi]
LID - 23259671211053012
AB  - BACKGROUND: Research has identified factors that influence achievement rates of 
      threshold scores on patient-reported outcome measures (PROMs) after hip 
      arthroscopy. However, little data exist on whether failure to achieve a threshold 
      score (minimal clinically important difference [MCID] or substantial clinical 
      benefit [SCB]) in the short term after hip arthroscopy predicts the risk of 
      future hip surgery. PURPOSE/HYPOTHESIS: The purpose of this study was to 
      determine if failure to achieve the MCID or SCB on PROMs within 1 year of hip 
      arthroscopy can be considered a risk factor for repeat surgery within 5 years of 
      primary hip arthroscopy. It was hypothesized that failure to achieve threshold 
      scores would increase the risk of subsequent hip surgery. STUDY DESIGN: 
      Case-control study; Level of evidence, 3. METHODS: A retrospective review of 
      prospectively collected data was completed. Four PROMs were collected 
      preoperatively and within 1 year of hip arthroscopy: modified Harris Hip Score, 
      Hip Outcome Score-Activities of Daily Living, Hip Outcome Score-Sports, and the 
      33-Item International Hip Outcome Tool. RESULTS: Two cohorts were formed: (1) a 
      study cohort (n = 88) composed of patients who underwent repeat hip surgery 
      within 5 years of hip arthroscopy and (2) a control cohort (n = 288) composed of 
      patients who did not require repeat hip surgery. The study cohort had 
      significantly (P < .001) lower scores on all postoperative PROMs, and a 
      significantly (P < .001) smaller percentage of the study cohort met the MCID and 
      SCB. Multivariable regression analysis demonstrated that not achieving the MCID 
      or SCB on each of the PROMs is an independent risk factor for repeat hip surgery. 
      For every PROM in which a patient failed to achieve the MCID, the odds of 
      subsequent surgery increased by 1.68 (95% CI, 1.42-1.98; P < .001). For every 
      PROM in which a patient failed to achieve the SCB, the odds of subsequent surgery 
      increased by 1.63 (95% CI, 1.35-1.97; P < .001). CONCLUSION: Failure to meet 
      threshold scores on PROMs after hip arthroscopy was an independent risk factor 
      for subsequent hip surgery. This study establishes a novel utility of PROMs and 
      confirms the importance of these metrics in the orthopaedic literature.
CI  - (c) The Author(s) 2021.
FAU - Feingold, Jacob D
AU  - Feingold JD
AD  - Hospital for Special Surgery, New York, New York, USA.
FAU - Swartwout, Erica L
AU  - Swartwout EL
AD  - Hospital for Special Surgery, New York, New York, USA.
FAU - Roberts, Sacha A
AU  - Roberts SA
AD  - Hospital for Special Surgery, New York, New York, USA.
FAU - Nwachukwu, Benedict U
AU  - Nwachukwu BU
AD  - Hospital for Special Surgery, New York, New York, USA.
FAU - Ranawat, Anil S
AU  - Ranawat AS
AD  - Hospital for Special Surgery, New York, New York, USA.
LA  - eng
PT  - Journal Article
DEP - 20211116
PL  - United States
TA  - Orthop J Sports Med
JT  - Orthopaedic journal of sports medicine
JID - 101620522
PMC - PMC8600560
OTO - NOTNLM
OT  - PROMs
OT  - femoroacetabular impingement
OT  - hip arthroscopy
OT  - hip preservation
OT  - sports medicine
COIS- One or more of the authors has declared the following potential conflict of 
      interest or source of funding: B.U.N. has received grant support from Arthrex, 
      education payments from Arthrex and Smith & Nephew, and hospitality payments from 
      Stryker and Wright Medical, and is the founder of and has an ownership interest 
      in BICMID. A.S.R. has received consulting fees from Arthrex, Anika, Bodycad, 
      Enhatch, Marrow Cellution, NewClip, Ranfac, Smith & Nephew, and Xiros; and 
      speaking fees from Pfizer; and has an ownership interest in Conformis and 
      Enhatch. AOSSM checks author disclosures against the Open Payments Database 
      (OPD). AOSSM has not conducted an independent investigation on the OPD and 
      disclaims any liability or responsibility relating thereto.
EDAT- 2021/11/23 06:00
MHDA- 2021/11/23 06:01
PMCR- 2021/11/16
CRDT- 2021/11/22 06:55
PHST- 2021/07/03 00:00 [received]
PHST- 2021/08/04 00:00 [accepted]
PHST- 2021/11/22 06:55 [entrez]
PHST- 2021/11/23 06:00 [pubmed]
PHST- 2021/11/23 06:01 [medline]
PHST- 2021/11/16 00:00 [pmc-release]
AID - 10.1177_23259671211053012 [pii]
AID - 10.1177/23259671211053012 [doi]
PST - epublish
SO  - Orthop J Sports Med. 2021 Nov 16;9(11):23259671211053012. doi: 
      10.1177/23259671211053012. eCollection 2021 Nov.